Rules-Based Medicine Competitors and Similar CompaniesClear all

Rules-Based Medicine's competitors and similar companies include Oxford Gene Technology, RayBiotech, Proteome Sciences and Olink.

	Rules-Based Medicine Rules-Based Medicine (RBM) is a company that operates as a multiplexed immunoassay testing laboratory.	Oxford Gene Technology Oxford Gene Technology (OGT) is a company specializing in molecular genetics.	RayBiotech RayBiotech is a life sciences company providing proteomic discovery tools to scientists.	Proteome Sciences Reaching New Heights in Biomarker Solutions-Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications	Olink Olink Proteomics is a company providing products and services for human protein biomarker discovery.
Founding Date	Founding Date 2002	Founding Date 1995	Founding Date 2001	Founding Date N/A	Founding Date 2004
Type	Type Subsidiary	Type Subsidiary	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech clinical research medical diagnostics project management	Tags Healthcare biotech genetics	Tags Technology biotech clinical research life sciences	Tags Healthcare healthtech life sciences medical diagnostics pharma	Tags Healthcare biotech pharma
Locations	Locations Austin, US HQ	Locations Begbroke, GB HQ Tarrytown, US	Locations Peachtree Corners, US HQ Madrid, ES	Locations Addlestone, GB HQ Frankfurt Am Main, DE Cobham, GB	Locations Uppsala, SE HQ Barcelona, ES Uppsala, SE Watertown, US
Employees	Employees 1551% increase	Employees 161	Employees 663% increase	Employees 363% increase	Employees 582
Financial
Revenue (est.)	Revenue (est.) $30m (FY, 2014)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) £3.8m (FY, 2025)	Revenue (est.) $169.6m (FY, 2023)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods £2.9m (FY, 2025)	Cost of goods $51.9m (FY, 2023)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit £845k (FY, 2025)	Gross profit $119.9m (FY, 2023)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income (£3.1m) (FY, 2025)	Net income ($31.6m) (FY, 2023)